You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial
|
---|---|
Published in |
Lancet Oncology, July 2007
|
DOI | 10.1016/s1470-2045(07)70148-1 |
Pubmed ID | |
Authors |
Martin R Stockler, Rachel O'Connell, Anna K Nowak, David Goldstein, Jane Turner, Nicholas RC Wilcken, David Wyld, Ehtesham A Abdi, Amanda Glasgow, Philip J Beale, Michael Jefford, Haryana Dhillon, Stephane Heritier, Candace Carter, Ian B Hickie, R John Simes, on behalf of the Zoloft's Effects on Symptoms and survival Time Trial Group |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 2% |
Hong Kong | 1 | <1% |
Norway | 1 | <1% |
Japan | 1 | <1% |
United States | 1 | <1% |
Unknown | 127 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 16 | 12% |
Student > Master | 16 | 12% |
Researcher | 15 | 11% |
Student > Ph. D. Student | 14 | 11% |
Student > Doctoral Student | 12 | 9% |
Other | 37 | 28% |
Unknown | 23 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 29% |
Psychology | 18 | 14% |
Unspecified | 16 | 12% |
Agricultural and Biological Sciences | 7 | 5% |
Nursing and Health Professions | 6 | 5% |
Other | 11 | 8% |
Unknown | 36 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2015.
All research outputs
#7,960,693
of 25,374,917 outputs
Outputs from Lancet Oncology
#4,091
of 6,882 outputs
Outputs of similar age
#26,985
of 78,616 outputs
Outputs of similar age from Lancet Oncology
#16
of 24 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 6,882 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,616 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.